Vitaspring Biomedical Co. Ltd. SEC filings VSBC

Vitaspring Biomedical Co. Ltd. has 74 filings in SEC EDGAR's recent list, going back to Mar 6, 2017. Its latest annual report, Form 10-K, was filed on Jun 17, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 17, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (officer or director change). The company's fiscal year ends on January 31.

Form Description Filed Period
10-Q Quarterly report Sep 17, 2026 Jul 31, 2026
NT 10-Q Form nt 10-q Sep 15, 2026 Jul 31, 2026
8-K Current report
Officer or director change
 Sep 10, 2026 Sep 7, 2026
10-K Annual report Jun 17, 2026 Jan 31, 2026
10-Q Quarterly report Jun 17, 2026 Apr 30, 2026
10-Q Quarterly report Jun 17, 2026 Oct 31, 2025
10-Q Quarterly report Jun 17, 2026 Jul 31, 2025
10-Q Quarterly report Jun 15, 2026 Apr 30, 2025
10-K Annual report Jun 8, 2026 Jan 31, 2025
10-Q Quarterly report May 6, 2026 Oct 31, 2024
10-Q Quarterly report Apr 22, 2026 Jul 31, 2024
10-Q Quarterly report Apr 2, 2026 Apr 30, 2024
10-K Annual report Mar 12, 2026 Jan 31, 2024
10-Q Quarterly report Jan 30, 2026 Oct 31, 2023
10-Q Quarterly report Jan 23, 2026 Jul 31, 2023
10-Q Quarterly report Jan 13, 2026 Apr 30, 2023
10-K Annual report Dec 1, 2025 Jan 31, 2023
8-K Current report
Auditor change
 Aug 25, 2025 Aug 19, 2025
8-K Current report
Auditor change, Officer or director change
 Aug 11, 2025 Aug 5, 2025
8-K Current report
Officer or director change, Other events
 Jul 29, 2025 Aug 26, 2022
NT 10-K Filing May 1, 2023 Jan 31, 2023
8-K Current report
Auditor change
 Jan 27, 2023 Jan 17, 2023
10-Q Quarterly report Dec 21, 2022 Oct 31, 2022
NT 10-Q Filing Dec 13, 2022 Oct 31, 2022
10-Q Quarterly report Sep 15, 2022 Jul 31, 2022
10-Q Quarterly report Jun 15, 2022 Apr 30, 2022
10-K Annual report May 3, 2022 Jan 31, 2022
10-Q Quarterly report Dec 23, 2021 Oct 31, 2021
NT 10-Q Filing Dec 15, 2021 Oct 31, 2021
10-Q Quarterly report Sep 15, 2021 Jul 31, 2021
8-K Current report
Officer or director change
 Aug 11, 2021 Aug 7, 2020
10-Q Quarterly report Jun 14, 2021 Apr 30, 2021
8-K Current report
Material agreement
 Apr 22, 2021 Mar 24, 2021
10-K Annual report Apr 14, 2021 Jan 31, 2021
10-Q Quarterly report Dec 15, 2020 Oct 31, 2020
8-K/A Amended current report
Material agreement
 Dec 2, 2020 Jul 14, 2020
8-K Current report
Material agreement
 Dec 1, 2020 Nov 24, 2020
10-Q Quarterly report Sep 28, 2020 Jul 31, 2020
NT 10-Q Filing Sep 14, 2020 Jul 31, 2020
8-K Current report
Unregistered share sale, Other events
 Aug 4, 2020 Jul 14, 2020
10-Q Quarterly report Jun 19, 2020 Apr 30, 2020
NT 10-Q Filing Jun 15, 2020 Apr 30, 2020
10-K Annual report Jun 9, 2020 Jan 31, 2020
NT 10-K Filing May 1, 2020 Jan 31, 2020
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
 Apr 27, 2020 Apr 21, 2020
8-K/A Amended current report
Change in control, Officer or director change
 Feb 26, 2020 Jan 21, 2020
8-K Current report
Officer or director change
 Jan 31, 2020 Jan 21, 2020
10-Q Quarterly report Dec 12, 2019 Oct 31, 2019
10-Q Quarterly report Aug 27, 2019 Jul 31, 2019
10-Q Quarterly report Jun 3, 2019 Apr 30, 2019
10-K Annual report Apr 26, 2019 Jan 31, 2019
8-K Current report
Officer or director change
 Apr 17, 2019 Apr 17, 2019
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
 Dec 12, 2018 Nov 29, 2018
10-Q Quarterly report Nov 21, 2018 Oct 31, 2018
10-Q Quarterly report Aug 15, 2018 Jul 31, 2018
10-Q Quarterly report Jun 4, 2018 Apr 30, 2018
10-K Annual report May 16, 2018 Jan 31, 2018
8-K Current report
Auditor change
 May 9, 2018 May 8, 2018
NT 10-K Form nt 10-k Apr 30, 2018 Jan 31, 2018
10-Q Quarterly report Nov 15, 2017 Oct 31, 2017
10-Q Quarterly report Aug 16, 2017 Jul 31, 2017
10-Q Quarterly report Jun 8, 2017 Apr 30, 2017
EFFECT Filing Jun 7, 2017 —
S-1/A Amended registration statement Jun 7, 2017 —
CORRESP Letter to the SEC Jun 5, 2017 —
S-1/A Amended registration statement Apr 27, 2017 —
UPLOAD Letter from the SEC Apr 25, 2017 —
S-1/A Amended registration statement Apr 19, 2017 —
UPLOAD Letter from the SEC Apr 18, 2017 —
S-1/A Amended registration statement Apr 12, 2017 —
UPLOAD Letter from the SEC Apr 5, 2017 —
S-1/A Amended registration statement Mar 30, 2017 —
UPLOAD Letter from the SEC Mar 28, 2017 —
S-1 Registration statement Mar 6, 2017 —

Showing 74 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
VSBC (OTC)
Fiscal year ends
January 31
Incorporated in
NV
Headquarters
Riverside, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1697884
Former names
Shemn Corp. (until Apr 27, 2020)

Other Services-Commercial Physical & Biological Research companies

All 17 Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.